Informação sobre produto
- Linzess Ammonium Salt
- 11: PN: WO2008151257 SEQID: 55 claimed protein Ammonium Salt 13: PN: WO2008151257 SEQID: 57 claimed protein Ammonium Salt
- 18: PN: WO2015054500 SEQID: 72 claimed protein Ammonium Salt
- 1: PN: WO2014131024 SEQID: 55 claimed protein Ammonium Salt,1: PN: WO2015054500 SEQID: 55 claimed protein Ammonium Salt,2074: PN: US20090062207 SEQID: 3 claimed protein Ammonium Salt
- 3: PN: WO2015054500 SEQID: 57 claimed protein Ammonium Salt
- 40: PN: WO2010065751 SEQID: 55 claimed protein Ammonium Salt
- 42: PN: WO2010065751 SEQID: 57 claimed protein Ammonium Salt,55: PN: US20100152118 SEQID: 55 claimed protein Ammonium Salt
- 55: PN: WO2011069038 SEQID: 55 claimed sequence Ammonium Salt
- 55: PN: WO2012037380 SEQID: 55 unclaimed protein Ammonium Salt
- 55: PN: WO2015054649 SEQID
- Ver mais sinónimos
Stability Hygroscopic
Applications This compound is a salt form of Linaclotide (L465880). Linaclotide is a guanylate cyclase-C agonist currently being studied in Phase 3 trials for the treatment of irritable bowel syndrome with constipation.
References Chey, W.D., et al.: Am. J. Gastroenterol., 107, 1702 (2012); Rao, S., et al.: Am. J. Gastroentrol., 107, 1714 (2012); Brierley, S.M., et al.: Curr. Opinion. Pharmacol., 12, 632 (2012);